|
A disintegrin and metalloproteinase domain 12 (meltrin alpha)
|
ADAM12
|
NP_067673
|
10q26.3
|
[45]
|
|
Actin alpha 1, alpha smooth muscle antigen
|
ACTA1/ASMA
|
NP_001091
|
1q42.13-q42.2
|
[45]
|
|
Apolipoprotein E
|
APOE
|
NP_000032
|
19q13.2
|
[45]
|
|
ATP-binding cassette, subfamily A, member 1
|
ABCA1
|
NP_005493
|
9q31.1
|
[45]
|
|
ATP-binding cassette, subfamily G, member 2
|
ABCG2/BCRP
|
NP_004818
|
4q22
|
[42,43]
|
|
Catenin (cadherin-associated protein), alpha 1 (102 kDa)
|
CTNNA1
|
NP_001894
|
5q31
|
[39]
|
|
CD44 antigen
|
CD44
|
NP_001001392
|
11p13
|
[38]
|
|
Chemokine (C–C motif) ligand 2
|
CCL2
|
NP_002973
|
17q11.2-q21.1
|
[45]
|
|
Cyclin D2
|
CCND2
|
NP_001750
|
12p13
|
[45]
|
|
Cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
CDKN1A
|
NP_510867
|
6p21.2
|
[49,50]
|
|
Decorin
|
DCN
|
NP_598014
|
12q13.2
|
[45]
|
|
Epithelial membrane protein 3
|
EMP3
|
NP_001416
|
19q13.3
|
[45]
|
|
Estrogen receptor 1
|
ESR1
|
NP_000116
|
6q25.1
|
[47, 49-51]
|
|
Fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome)
|
FGFR1
|
NP_075599
|
8p11.2-p11.1
|
[45]
|
|
Flotillin 2 (epithelial-specific antigen)
|
FLOT2/ESA
|
NP_004466
|
17q11-q12
|
[36,37,44,51]
|
|
Four and a half LIM domains 1
|
FHL1
|
NP_001440
|
Xq26
|
[45]
|
|
Frizzled homolog 2 (Drosophila)
|
FZD2
|
NP_001457
|
17q21.1
|
[45]
|
|
FYN oncogene related to SRC, FGR, YES
|
FYN
|
NP_694593
|
6q21
|
[45]
|
|
Glycoprotein (transmembrane) nmb
|
GPNMB
|
NP_002501
|
7p15
|
[45]
|
|
Glypican 4
|
GPC4
|
NP_001439
|
Xq26.1
|
[45]
|
|
Growth-associated protein 43
|
GAP43
|
NP_002036
|
3q13.1-q13.2
|
[45]
|
|
Growth hormone receptor
|
GHR
|
NP_000154
|
5p13-p12
|
[45]
|
|
Insulin-like growth factor 2 receptor
|
IGF2R
|
NP_000867
|
6q26
|
[45]
|
|
Insulin-like growth factor binding protein 4
|
IGFBP4
|
NP_001543
|
17q12-q21.1
|
[45]
|
|
Insulin-like growth factor binding protein 7
|
IGFPP7
|
NP_001544
|
4q12
|
[45]
|
|
Integrin, alpha 6
|
ITGA6
|
NP_000201
|
2q31.1
|
[36,37,45]
|
|
Keratin 19
|
KRT19
|
NP_002267
|
17q21.2
|
[48-50]
|
|
Lymphocyte antige 6 complex, sca-1
|
LY6A/SCA-1
|
NP_034868
|
15
|
[40,41,43]
|
|
Membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10)
|
MME/CALLA/CD10
|
NP_009220
|
3q25.1-q25.2
|
[36,37,45,49,51]
|
|
Mucin 1 (transmembrane), epithelial membrane antigen
|
MUC1/EMA
|
NP_877418
|
1q21
|
[36,37, 43-45, 49,51]
|
|
Musashi homolog 1 (Drosophila)
|
MSI1
|
NP_002433
|
12q24.1-q24.31
|
[49,50]
|
|
Nidogen (enactin)
|
NID
|
NP_002499
|
1q43
|
[45]
|
|
Notch homolog 1, translocation-associated (Drosophila)
|
NOTCH1
|
NP_060087
|
9q34.3
|
[49]
|
|
Notch homolog 3 (Drosophila)
|
NOTCH3
|
NP_000426
|
19p13.2-p13.1
|
[45]
|
|
Notch homolog 4 (Drosophila)
|
NOTCH4
|
NP_004548
|
6p21.3
|
[49]
|
|
P53 target zinc finger protein
|
WIG1
|
NP_689426
|
3q26.3-q27
|
[45]
|
|
Periostin, osteoblast specific factor
|
POSTN
|
NP_006466
|
13q13.3
|
[45]
|
|
Platelet-derived growth factor receptor, beta polypeptide
|
PDGFRB
|
NP_002600
|
5q31-q32
|
[45]
|
|
Polycystic kidney disease 2 (autosomal dominant)
|
PKD2
|
NP_000288
|
4q21-q23
|
[45]
|
|
Progesterone receptor
|
PGR
|
NP_000917
|
11q22-q23
|
[41,47,49,50]
|
|
Prostate tumor overexpressed gene 1
|
PTOV1
|
NP_059128
|
19q13.33
|
[45]
|
|
Retinoic acid receptor responder (tazarotene induced) 3
|
RARRES3
|
NP_004576
|
11q23
|
[45]
|
|
Stem cell growth factor; lymphocyte secreted C-type lectin
|
SCGF
|
NP_002966
|
19q13.3
|
[45]
|
|
Telomerase reverse transcriptase
|
TERT
|
NP_937986
|
5p15.33
|
[43]
|
|
Tenascin C (hexabrachion)
|
TNC
|
NP_002151
|
9q33
|
[45]
|
|
Tight junction protein 1 (zona occludens 1)
|
TJP1
|
NP_783297
|
15q13
|
[39]
|
|
Tissue inhibitor of metalloproteinase 3
|
TIMP3
|
NP_000353
|
22q12.1-q13.2
|
[45]
|
|
Wiskott–Aldrich syndrome protein interacting protein
|
WASPIP
|
NP_003378
|
2q31.1
|
[45]
|
